This is a useful policy paper that assesses the total level of spending needed for AIDS vaccine research and development in the near future and the gap between current and projected spending. It considers the main stumbling blocks in vaccine research and development that could be significantly overcome with sufficient increase in spending: identification of high-quality candidate vaccines, increasing the number of such candidates entering clinical trials, and speeding up the establishment of clinical trials with faster recruitment of volunteers and regulatory approval.